Latin America Migraine Drugs Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	November, 2022	INF17509674

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	November, 2022
SKU	INF17509674

Global Migraine Drugs Market In Latin America 2023-2027

Technavio has been monitoring the migraine drugs market in Latin America and it is poised to grow by $82.31 mn during 2023-2027, accelerating at a CAGR of 5.82% during the forecast period. Our report on the migraine drugs market in Latin America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current regional market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of migraine in Latin America, the growing number of migraine treatment awareness programs, and drug reformulations.

Technavio's migraine drugs market in Latin America is segmented as below:

By End-user

Hospital
Retail
Online

This study identifies the introduction of new classes of drugs with higher clinical efficacy as one of the prime reasons driving the migraine drugs market in Latin America's growth during the next few years. Also, the rise in the popularity of devices for migraine treatment and rising advances in migraine drugs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the migraine drugs market in Latin America covers the following areas:

Migraine drugs market sizing in Latin America
Migraine drugs market forecast in Latin America
Migraine drugs market industry analysis in Latin America

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading migraine drugs markets in Latin America vendors that include AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals Inc., Bausch Health Co. Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Ethypharm SAS, GlaxoSmithKline Plc, H Lundbeck AS, IntelGenx Technologies Corp., Klaria Pharma Holding AB, Kowa Co. Ltd., OptiNose Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and UCB SA. Also, the migraine drugs market in Latin America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Country Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Therapy
  - Table Executive Summary – Chart on Market Segmentation by End-user
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Latin America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Regional - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Latin America: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Historic Market Size
- Migraine Drugs Market in Latin America 2017 - 2021
  - Table Historic Market Size – Data Table on Migraine Drugs Market in Latin America 2017 – 2021 ($ million)
- Therapy Segment Analysis 2017 - 2021
  - Table Historic Market Size – Therapy Segment 2017 - 2021 ($ million)
- End-User Segment Analysis 2017 - 2021
  - Table Historic Market Size – End-User Segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Therapy
- Market segments
  - Table Chart on Therapy - Market share 2022-2027 (%)
  - Table Data Table on Therapy - Market share 2022-2027 (%)
- Comparison by Therapy
  - Table Chart on Comparison by Therapy
  - Table Data Table on Comparison by Therapy
- Preventive treatment - Market size and forecast 2022- 2027
  - Table Chart on Preventive treatment - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Preventive treatment - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Preventive treatment - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Preventive treatment - Year-over-year growth 2022-2027 (%)
- Abortive treatment - Market size and forecast 2022-2027
  - Table Chart on Abortive treatment - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Abortive treatment - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Abortive treatment - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Abortive treatment - Year-over-year growth 2022-2027 (%)
- Market opportunity by Therapy
  - Table Market opportunity by Therapy ($ million)
Market Segmentation by End-user
- Market segments
  - Table Chart on End-user - Market share 2022-2027 (%)
  - Table Data Table on End-user - Market share 2022-2027 (%)
- Comparison by End-user
  - Table Chart on Comparison by End-user
  - Table Data Table on Comparison by End-user
- Hospital - Market size and forecast 2022-2027
  - Table Chart on Hospital - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Hospital - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Hospital - Year-over-year growth 2022-2027 (%)
- Retail - Market size and forecast 2022-2027
  - Table Chart on Retail - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Retail - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Retail - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Retail - Year-over-year growth 2022-2027 (%)
- Online - Market size and forecast 2022-2027
  - Table Chart on Online - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Online - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Online - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Online - Year-over-year growth 2022-2027 (%)
- Market opportunity by End-user
  - Table Market opportunity by End-user ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography - 2022-2027 (%)
  - Table Data Table on Market share by geography - 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- Mexico - Market size and forecast 2022-2027
  - Table Chart on Mexico - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Mexico - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Mexico - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Mexico - Year-over-year growth 2022-2027 (%)
- Brazil - Market size and forecast 2022-2027
  - Table Chart on Brazil - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Brazil - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Brazil - Year-over-year growth 2022-2027 (%)
- Argentina - Market size and forecast 2022-2027
  - Table Chart on Argentina - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Argentina - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Argentina - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Argentina - Year-over-year growth 2022-2027 (%)
- Chile - Market size and forecast 2022-2027
  - Table Chart on Chile - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Chile - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Chile - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Chile - Year-over-year growth 2022-2027 (%)
- Rest of Latin America - Market size and forecast 2022- 2027
  - Table Chart on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of Latin America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of Latin America - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increasing prevalence of migraine in Latin America
  - Growing number of migraine treatment awareness programs
  - Drug reformulations
- Market challenges
  - Concerns related to side effects of migraine drugs
  - Regulations associated with migraine drugs
  - Lack of proper diagnoses of migraine
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Introduction of new classes of drugs with higher clinical efficacy
  - Rise in popularity of devices for migraine treatment
  - Rising advances in migraine drugs
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key offerings
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- Amneal Pharmaceuticals Inc.
  - Table Amneal Pharmaceuticals Inc. - Overview
  - Table Amneal Pharmaceuticals Inc. - Business segments
  - Table Amneal Pharmaceuticals Inc. - Key news
  - Table Amneal Pharmaceuticals Inc. - Key offerings
  - Table Amneal Pharmaceuticals Inc. - Segment focus
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Daiichi Sankyo Co. Ltd.
  - Table Daiichi Sankyo Co. Ltd. - Overview
  - Table Daiichi Sankyo Co. Ltd. - Business segments
  - Table Daiichi Sankyo Co. Ltd. - Key news
  - Table Daiichi Sankyo Co. Ltd. - Key offerings
  - Table Daiichi Sankyo Co. Ltd. - Segment focus
- Eli Lilly and Co.
  - Table Eli Lilly and Co. - Overview
  - Table Eli Lilly and Co. - Product / Service
  - Table Eli Lilly and Co. - Key offerings
- Endo International Plc
  - Table Endo International Plc - Overview
  - Table Endo International Plc - Business segments
  - Table Endo International Plc - Key news
  - Table Endo International Plc - Key offerings
  - Table Endo International Plc - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- H Lundbeck AS
  - Table H Lundbeck AS - Overview
  - Table H Lundbeck AS - Product / Service
  - Table H Lundbeck AS - Key offerings
- IntelGenx Technologies Corp.
  - Table IntelGenx Technologies Corp. - Overview
  - Table IntelGenx Technologies Corp. - Product / Service
  - Table IntelGenx Technologies Corp. - Key offerings
- Klaria Pharma Holding AB
  - Table Klaria Pharma Holding AB - Overview
  - Table Klaria Pharma Holding AB - Product / Service
  - Table Klaria Pharma Holding AB - Key offerings
- Kowa Co. Ltd.
  - Table Kowa Co. Ltd. - Overview
  - Table Kowa Co. Ltd. - Product / Service
  - Table Kowa Co. Ltd. - Key offerings
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
- UCB SA
  - Table UCB SA - Overview
  - Table UCB SA - Product / Service
  - Table UCB SA - Key offerings
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations